Clinical Trial Update: Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the duration of effect of Bimatoprost SR in participants with open-angle glaucoma or ocular hypertension. The study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Bimatoprost SR (bimatoprost)

Snippet

Sponsor: AbbVie | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED